| 1. | | | Antibiotic induced biofilm formation of novel multidrug resistant Acinetobacter baumannii ST2121 clone
|
| 2. | | | Antibiotic resistance of Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units
|
| 3. | | | Carbapenem resistance in Acinetobacter baumannii is associated with enhanced survival on hospital fabrics
|
| 4. | | | Characterization of antibiotic and disinfectant susceptibility in biofilm-forming Acinetobacter baumannii: A focus on environmental isolates
|
| 5. | | | Characterization of disinfectant susceptibility profiles among clinical isolates of Acinetobacter baumannii in Ardabil, Iran
|
| 6. | | | Characterization of imipenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a Moroccan hospital
|
| 7. | | | Clonal spread of PER-1 and OXA-23 producing extensively drug resistant Acinetobacter baumannii during an outbreak in a burn intensive care unit in Tunisia
|
| 8. | | | Comprehensive whole-genome sequencing reveals the resistome, virulome, and mobile genetic architecture of multidrug-resistant Acinetobacter baumannii
|
| 9. | | | Correlation of biofilm formation and antibiotic resistance among clinical and soil isolates of Acinetobacter baumannii in Iraq
|
| 10. | | | Correlation of RND efflux pump expression and AdeRS mutations in tigecycline-resistant Acinetobacter baumannii from Thai clinical isolates
|
| 11. | | | Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran
|
| 12. | | | Detection of bla NDM-1, bla OXA-23, and bla OXA-58 positive Acinetobacter baumannii in an intensive care unit in Brazil
|
| 13. | | | Detection of efflux pump genes in multiresistant Acinetobacter baumannii ST2 in Iran
|
| 14. | | | Effect of aminoglycosides on surface hydrophobicity of Acinetobacter baumannii
|
| 15. | | | Emergence of colistin resistant Acinetobacter baumannii clonal complex 2 (CC2) among hospitalized patients in Iran
|
| 16. | | | First isolation of carbapenem-resistant Acinetobacter beijerinckii from an environmental sample
|
| 17. | | | Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia
|
| 18. | | | Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates
|
| 19. | | | Genotypic analysis and biofilm formation of Acinetobacter baumannii clinical isolates
|
| 20. | | | High prevalence of OXA-type carbapenemases among Acinetobacter baumannii strains in a teaching hospital of Tehran
|
| 21. | | | In vitro activity of ceftazidime-avibactam, imipenem-cilastatin-relebactam, meropenem-vaborbactam, cefiderocol, and plazomicin against non-fermenting Gram-negative isolates obtained from Bulgarian ...
|
| 22. | | | In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring bla OXA-23-like and bla OXA-24-like genes: A multicenter based study
|
| 23. | | | Intenzív osztályokról származó Acinetobacter calcoaceticus törzsek antibiotikum rezisztenciája
|
| 24. | | | Investigation of carbapenem resistant Acinetobacter baumannii ST2 in Iran
|
| 25. | | | Molecular detection of aminoglycoside-modifying enzyme genes in Acinetobacter baumannii clinical isolates
|
| 26. | | | Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured during the Eastern Ukrainian Conflict
|
| 27. | | | Prevalence and molecular mechanisms of colistin resistance in Acinetobacter baumannii clinical isolates in Tehran, Iran
|
| 28. | | | Prevalence of carbapenem-hydrolyzing OXA-type ß-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection
|
| 29. | | | Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans
|
